Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 3:21 pm Purchase | 2024-12-31 | 13G | Theratechnologies Inc. THTX | MORGAN STANLEY MS | 2,313,769 5.000% | 2,313,769 (New Position) | Filing History |
| 2025-02-10 08:24 am Sale | 2024-12-31 | 13G | Theratechnologies Inc. THTX | HIRSCHMAN ORIN | 3,026,569 6.100% | -692,733 (-18.63%) | Filing History |
| 2024-11-14 4:53 pm Unchanged | 2024-09-30 | 13G | Theratechnologies Inc. THTX | Nantahala Capital Management LLC | 2,682,228 5.833% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | Theratechnologies Inc. THTX | Nantahala Capital Management LLC | 2,682,228 5.800% | 2,682,228 (New Position) | Filing History |
| 2024-02-07 6:55 pm Sale | 2023-12-31 | 13G | Theratechnologies Inc. THTX | HIRSCHMAN ORIN | 3,719,302 8.100% | -429,761 (-10.36%) | Filing History |
| 2023-11-29 4:32 pm Purchase | 2023-10-26 | 13G | Theratechnologies Inc. THTX | HIRSCHMAN ORIN | 4,149,063 9.000% | 4,149,063 (New Position) | Filing History |
| 2023-11-28 4:52 pm Purchase | 2023-11-27 | 13D | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 5,188,876 10.500% | 5,188,876 (New Position) | Filing History |
| 2023-11-13 4:05 pm Purchase | 2023-10-31 | 13D | Theratechnologies Inc. THTX | Investissement Quebec | 9,118,184 19.900% | 9,118,184 (New Position) | Filing History |
| 2023-02-14 08:14 am Purchase | 2022-12-31 | 13G | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 2,587,281 10.700% | 168,304 (+6.96%) | Filing History |
| 2023-02-10 10:58 am Purchase | 2022-12-30 | 13G | Theratechnologies Inc. THTX | MORGAN STANLEY MS | 1,969,351 8.300% | 683,596 (+53.17%) | Filing History |
| 2022-11-14 5:00 pm Purchase | 2022-11-11 | 13G | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 2,418,977 10.010% | 108,457 (+4.69%) | Filing History |
| 2022-02-11 3:07 pm Purchase | 2021-12-31 | 13G | Theratechnologies Inc. THTX | MORGAN STANLEY MS | 1,285,755 5.400% | 1,285,755 (New Position) | Filing History |
| 2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 2,310,521 9.600% | 454,175 (+24.47%) | Filing History |
| 2022-02-10 3:14 pm Sale | 2021-12-31 | 13G | Theratechnologies Inc. THTX | STEWARDSHIP PARTNERS INVESTMENT COUNSEL INC. | 983,995 4.160% | -662,080 (-40.22%) | Filing History |
| 2021-02-23 4:11 pm Purchase | 2021-01-19 | 13G | Theratechnologies Inc. THTX | Soleus Capital Master Fund, L.P. | 1,856,346 7.800% | 1,856,346 (New Position) | Filing History |
| 2021-02-11 2:02 pm Sale | 2020-12-31 | 13G | Theratechnologies Inc. THTX | STEWARDSHIP PARTNERS INVESTMENT COUNSEL INC. | 1,646,075 8.550% | -58,751 (-3.45%) | Filing History |